293 related articles for article (PubMed ID: 28976455)
21. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI).
Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL
Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119
[TBL] [Abstract][Full Text] [Related]
22. Fecal microbiota transplantation in cancer management: Current status and perspectives.
Chen D; Wu J; Jin D; Wang B; Cao H
Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
[TBL] [Abstract][Full Text] [Related]
23. Microbiota Replacement Therapies: Innovation in Gastrointestinal Care.
Khanna S
Clin Pharmacol Ther; 2018 Jan; 103(1):102-111. PubMed ID: 29071710
[TBL] [Abstract][Full Text] [Related]
24. Donor Considerations in Fecal Microbiota Transplantation.
Barnes D; Park KT
Curr Gastroenterol Rep; 2017 Mar; 19(3):10. PubMed ID: 28289858
[TBL] [Abstract][Full Text] [Related]
25. A Retrospective Comparison of Fecal Microbial Transplantation Methods for Recurrent Clostridium Difficile Infection.
Cohen NA; Livovsky DM; Yaakobovitch S; Ben Yehoyada M; Ben Ami R; Adler A; Guzner-Gur H; Goldin E; Santo ME; Halpern Z; Paz K; Maharshak N
Isr Med Assoc J; 2016 Oct; 18(10):594-599. PubMed ID: 28471618
[TBL] [Abstract][Full Text] [Related]
26. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R
J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106
[TBL] [Abstract][Full Text] [Related]
27. Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome.
Camacho-Ortiz A; Gutiérrez-Delgado EM; Garcia-Mazcorro JF; Mendoza-Olazarán S; Martínez-Meléndez A; Palau-Davila L; Baines SD; Maldonado-Garza H; Garza-González E
PLoS One; 2017; 12(12):e0189768. PubMed ID: 29261736
[TBL] [Abstract][Full Text] [Related]
28. Effects of fecal microbiota transplantation for recurrent Clostridium difficile infection in children on kidney replacement therapy: a pilot study.
Samaey A; Vázquez-Castellanos JF; Caenepeel C; Evenepoel P; Vermeire S; Raes J; Knops N
Pediatr Nephrol; 2024 Apr; 39(4):1201-1212. PubMed ID: 37775582
[TBL] [Abstract][Full Text] [Related]
29. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.
Fischer M; Sipe B; Cheng YW; Phelps E; Rogers N; Sagi S; Bohm M; Xu H; Kassam Z
Gut Microbes; 2017 May; 8(3):289-302. PubMed ID: 28001467
[TBL] [Abstract][Full Text] [Related]
30. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
Tang G; Yin W; Liu W
Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517
[TBL] [Abstract][Full Text] [Related]
31. Precision medicine and gut dysbiosis.
Harris C; Kim PT; Waterhouse D; Feng Z; Niergarth J; Lee CH
Healthc Manage Forum; 2020 May; 33(3):107-110. PubMed ID: 31934800
[No Abstract] [Full Text] [Related]
32. [Fecal microbiota transplantation].
Lübbert C; Salzberger B; Mössner J
Internist (Berl); 2017 May; 58(5):456-468. PubMed ID: 28235986
[TBL] [Abstract][Full Text] [Related]
33. Multidrug-Resistant Gram-Negative Bacteria Decolonization in Immunocompromised Patients: A Focus on Fecal Microbiota Transplantation.
Alagna L; Palomba E; Mangioni D; Bozzi G; Lombardi A; Ungaro R; Castelli V; Prati D; Vecchi M; Muscatello A; Bandera A; Gori A
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764526
[TBL] [Abstract][Full Text] [Related]
34. Fecal microbiota transplantation stimulates type 2 and tolerogenic immune responses in a mouse model.
Moreau GB; Naz F; Petri WA
Anaerobe; 2024 Apr; 86():102841. PubMed ID: 38521227
[TBL] [Abstract][Full Text] [Related]
35. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
Carlucci C; Petrof EO; Allen-Vercoe E
EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease.
Kerman DH
Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):707-17. PubMed ID: 27633598
[TBL] [Abstract][Full Text] [Related]
37. Current and future trends in clostridioides (clostridium) difficile infection management.
Khanna S; Gerding DN
Anaerobe; 2019 Aug; 58():95-102. PubMed ID: 31054313
[TBL] [Abstract][Full Text] [Related]
38. Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: Establishment and implementation.
Lin TC; Hung YP; Ko WC; Ruan JW
J Microbiol Immunol Infect; 2019 Dec; 52(6):841-850. PubMed ID: 31607571
[TBL] [Abstract][Full Text] [Related]
39. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
[TBL] [Abstract][Full Text] [Related]
40. Update on intestinal microbiota in Crohn's disease 2017: Mechanisms, clinical application, adverse reactions, and outlook.
Shen Z; Zhu C; Quan Y; Yuan W; Wu S; Yang Z; Luo W; Tan B; Wang X
J Gastroenterol Hepatol; 2017 Nov; 32(11):1804-1812. PubMed ID: 28677158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
